In parallel, recent multi-omics studies have identified immune-regulatory and inflammatory genes—such as BTN3A2 and C4A—as contributors to BPH pathogenesis, implicating inherited differences in immune modulation and oxidative stress response as potential biological drivers of inter-individual and inter-regional variation [30]. This evidence concerns the gene C4A and benign prostatic hyperplasia.